Home > Cashflow Statement > INDO US BIOTECH

INDO US BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
AD     Remove this Ad

INDO US BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-1.48 Cr₹1.22 Cr₹6.29 Cr₹2.41 Cr₹1.46 Cr

What is the latest Cash Flow from Financing Activities ratio of INDO US BIOTECH ?

The latest Cash Flow from Financing Activities ratio of INDO US BIOTECH is ₹-1.48 Cr based on Mar2025 Standalone results.
Year Cash Flow from Financing Activities
Mar2025₹-1.48 Cr
Mar2024₹1.22 Cr
Mar2023₹6.29 Cr
Mar2022₹2.41 Cr
Mar2021₹1.46 Cr

How is Cash Flow from Financing Activities of INDO US BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-1.48 Cr
Negative
Mar2024 ₹1.22 Cr
-80.68
Mar2023 ₹6.29 Cr
160.95
Mar2022 ₹2.41 Cr
64.96
Mar2021 ₹1.46 Cr -

Compare Cash Flow from Financing Activities of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹254.4 Cr -3.9% 3% -46.9% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,264.8 Cr -0.5% -8.2% -18.3% Stock Analytics
KAVERI SEED COMPANY ₹4,704.6 Cr 5.4% -7.5% -0.9% Stock Analytics
VENKYS (INDIA) ₹2,184.0 Cr 1.1% -3.9% -11.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹953.7 Cr -5.1% -16.6% -40.4% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹393.5 Cr -6.7% -16.4% -0.6% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-3.9%

3%

-46.9%

SENSEX

1.7%

-1.7%

10.3%


You may also like the below Video Courses